Salbutamol modifies the neuromuscular junction in a mouse model of ColQ myasthenic syndrome. [electronic resource]
Producer: 20200312Description: 2339-2351 p. digitalISSN:- 1460-2083
- Acetylcholinesterase -- genetics
- Adrenergic beta-Agonists -- therapeutic use
- Agrin -- metabolism
- Albuterol -- therapeutic use
- Animals
- Collagen -- genetics
- Disease Models, Animal
- Dystroglycans -- metabolism
- Mice
- Mice, Knockout
- Muscle Fibers, Skeletal -- cytology
- Muscle Proteins -- genetics
- Muscle Weakness -- therapy
- Myasthenic Syndromes, Congenital -- drug therapy
- Neuromuscular Junction -- diagnostic imaging
- Receptors, Cholinergic
- Signal Transduction
- Synaptic Transmission -- physiology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.